TARS
TARS
NASDAQ · Pharmaceuticals

Tarsus Pharmaceuticals Inc

$63.39
+0.23 (+0.36%)
As of Jun 22, 1:41 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +28.6% upside
Low Target $66.63
Average Target $81.52
High Target $107.19
Current Price $63.39
Current
$63.39
Target
$81.52
$66.63 $81.52 avg $107.19
Scenario Analysis
Bear Case
$66.63
5.1%
Low target
Base Case
$81.52
+28.6%
Avg target
Bull Case
$107.19
+69.1%
High target
Risk/Reward
13.5x
Highly favorable
Price in Context
52-Week High
$85.25
-25.6% from high
52-Week Low
$38.51
+64.6% from low
50-Day SMA
$73.37
-13.6% vs SMA
200-Day SMA
$59.46
+6.6% vs SMA
RSI (14)
49.6
Neutral
Target vs 52W High
$81.52
-4.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%